Delivery Order SPE2DB22D1052-SPE2DB24FU8NR
Award Date 2/24/24
Potential Completion Date 2/26/24
Potential Value $4.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,567,171,124 units of ondansetron ODT 4 mg tablets in packages of 30 to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,811.42, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order with a completion date of February 6, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- This federal contract award is for the delivery of 4,565,255,906 units of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA). The $15,177.45 contract is a Firm Fixed Price Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- This federal contract award is for the delivery of 4,563,714,087 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s to the Defense Logistics Agency (DLA). The $3,846.83 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical supplies to U.S. government...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $18,770.38 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,604,432 units of ondansetron ODT 4 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,643,171 units of Ondansetron ODT 8 mg tablets in 30-count packages. The $2,239.95 contract has a completion date of February 14, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is part of a...
- This federal contract award is for the delivery of 4,564,313,859 units of ondansetron ODT 4 mg tablets to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $3,795.23 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 4,563,971,285 units of the medication Ondansetron ODT 4 mg Tablet. The $24,983.87 contract has a performance period through March 15, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,087 units of Ondansetron ODT 4 mg tablets. The $4,464.67 contract has an ultimate completion date of April 11, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,496,328 ondansetron ODT 4 mg tablets. The contract has a potential value of $25,005.60 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical products and medical supplies to the Department of Defense through an indefinite delivery...
- This federal contract award is for the provision of 4,564,286,476 tablets of the pharmaceutical product Ondansetron ODT 4 mg. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price of $2,446.69 and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of...